Clinico-pathologic Study of 6 Cases of Gastric Endocrine Cell Carcinoma - Case Report

Therapeutic Research

Volumn 24, Issue 11, 2003, Pages 2109-2115

  Maekawa, Hiroshi ^a   Machida, Michio ^a   Sato, Koichi ^a   Yabuki, Kiyotaka ^a   Maekawa, Takeo ^a   Wada, Ryo ^a   Matsumoto, Michio ^a  

^a JUNTENDO UNIVERSITY   (Japan)

Author keywords

Endocrine cell carcinoma; Immunohistochemical staining; Stomach

Indexed keywords

DIHYDROPYRIMIDINE DEHYDROGENASE; KI 67 ANTIGEN; OXIDOREDUCTASE; PROTEIN P53; STEM CELL FACTOR; THYMIDYLATE SYNTHASE; VASCULOTROPIN;

ADULT; AGED; ARTICLE; BACTERIAL PNEUMONIA; CLINICAL ARTICLE; ENDOCRINE TUMOR; GASTRECTOMY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER FAILURE; LIVER METASTASIS; MALE; PATHOLOGY; STOMACH CARCINOMA;

EID: 0347363594     PISSN: 02898020     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Matsusaka T, et al. Oat-cell carcinoma of the stomach. Fukuoka Acta Med 1976;67:65-7.
2. Matsui K, et al. Small cell carcinoma of the stomach: a clinicopathologic study of 17 cases. Am J gastroenterol 1991;86:1167-75.
3. Rindi G, et al. Gastric carcinoids and neuroendocrine carcinomas: pathogenesis, pathology, and behavior. World J Surg 1996;20:168-72.
4. Matsui K, et al. Clinicopathological features of neuroendocrine carcinomas of the stomach: appraisal of small cell and large cell variants. Arch Pathol Lab Med 1998;122:1010-7.
5. Otsuji E, et al. Malignant endocrine carcinoma of the stomach. Hepato-gastroenterology 2000;47:601-4.
6. Matsusaka T. Solid undifferentiated carcinomas of the stomach: a histological study with a supplement search for argyrophil cells. Fukuoka Igaku Zasshi 1976;67:165-87.
7. Ibrahim NBN, et al. Extrapulmonary oat cell carcinoma. Cancer 1984;54:1645-61.
8. Rindi G. Clinicopathologic aspects of gastric neuroendocrine tumors. Am J Surg Pathol 1995;19(Suppl 1):20-9.
9. Minagawa T, et al. Clinico-pathological study on five cases of small cell carcinoma of the stomach. Jpn J Clin Surg 2000;61:2341-6.
10. Kimura H, et al. Highly aggressive behavior and poor prognosis of small-cell carcinoma in the alimentary tract: flow-cytometric analysis and immunohistochemical staining for the p53 protein and proliferating cell nuclear antigen. Dig Surg 1999;16:152-7.
11. Yonemura Y, et al. Growth fraction in gastric carcinomas determined with monoclonal antibody Ki-67. Cancer 1990;65:1130-4.
12. Mercer WE, et al. Role of the p53 protein in cell proliferation as studied by microinjection of monoclonal antibodies. Mol Cell Biol 1984;4:276-82.
13. Tanaka S, et al. The evaluation of the biological aggressiveness of endocrine cell carcinoma of the stomach with proliferating cell nuclear antigen and Ki-67 labeling index. Jpn J Dig Surg 1996;29:795-9.
14. Rindi G, et al. ECL cell tumor and poorly differentiated endocrine carcinoma of the stomach: prognostic evaluation by pathological analysis. Gastroenterology 1999;116:532-42.
15. Kimura H, et al. Highly aggressive behavior and poor prognosis of small cell carcinoma in the stomach: flow cytometric and immunohistochemical analysis. Oncol Rep 1999;6:767-72.
16. Maeda K, et al. Combined analysis of vascular endothelial growth factor and platelet-derived endothelial growth factor expression in gastric carcinoma. Int J Cancer 1997;74:545-50.
17. Fukuda T, et al. Early gastric cancer of the small cell type. Am J Gastroenterol 1988;83:1176-9.
18. Futagami F, et al. A case of small cell carcinoma of the stomach with multiple liver and lung metastases successfully treated by combined chemotherapy with cisplatin and etoposide. Jpn J Cancer Chemother 1999;26:149-52. (in Japanese)
19. Sakai K, et al. A case of complete remission of gastric endocrine cell carcinoma with multiple bone metastasis by combination chemotherapy and high-dose chemotherapy with autologus peripheral blood stem cell transplantation. Jpn J Cancer Chemother 1997;24:2277-80. (in Japanese)
20. Hirama K, et al. Two cases of gastric small cell carcinoma responding to postoperative chemotherapy with modified EAP regimen. Jpn J Clin Surg 1998;59:983-9. (in Japanese)
21. Akasofu M, et al. An autopsy case of gastric small cell carcinoma in which the tumor completely disappeared with chemotherapy. Jpn J Cancer Clin 1999;45:143-9. (in Japanese)
22. Ueshige N, et al. Recurrent gastric carcinoma (endocrine cell type) successfully treated with combination chemotherapy: a case report. Jpn J Clin Surg 2000;61:1469-73. (in Japanese)
23. Fujita M, et al. A case of gastric endocrine cell carcinoma with remarkable lymph node metastasis resected after neoadjuvant chemotherapy. Jpn J Clin Surg 2002;63:900-3.(in Japanese)
24. Huang C-L, et al. Intratumoral expression of thymidylate synthase and dihydropyrimidine dehydrogenase in non-small cell lung cancer patients treated with 5-FU-based chemotherapy. Int J Oncol 2000;17:47-54.
25. Sugiyama Y, et al. Retrospective study on thymidylate synthase as a predictor of outcome and sensitivity to adjuvant chemotherapy in patients with curatively resected colorectal cancer. Anti-Cancer Drugs 2002;13:931-8.
26. Horiguchi J, et al. Prognostic significance of dihydropyrimidine dehydrogenase expression in breast cancer. Br J Cancer 2002;86:222-5.
27. Ichikawa W, et al. Combination of dihydropyrimidine dehydrogenase and thymidylate synthase gene expressions in primary tumors as predictive chemotherapy for metastatic colorectal cancer. Clic Cancer Res 2003;9:786-91.
28. Heinrich MC, et al. Inhibition of tyrosine kinase activity: a novel molecular approach to the treatment of kit-positive malignancies. J Clin Oncol 2002;20:1692-703.
29. Krystal GW, et al. The selective kinase inhibitor ST1571 inhibits small cell lung cancer growth. Clin Cancer Res 2000;6:3319-26.